

Bayer Bioscience Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 8.36 Cr
- Company Age 48 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 62.21 Cr
- Revenue Growth -24.12%
- Profit Growth -73.38%
- Ebitda 6.82%
- Net Worth -61.67%
- Total Assets -38.69%
About Bayer Bioscience
Bayer Bioscience Private Limited (BBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 February 1977 and has a history of 48 years and one month. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Pioneer Seed Company Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.36 Cr.
The company currently has active open charges totaling ₹62.21 Cr.
Simon Wiebusch, Pravin Trama, and Rupendra Singh serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74899MH1977PTC179722
- Company No.
179722
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Feb 1977
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Bayer Bioscience?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Simon Wiebusch ![]() | Director | 23-Jan-2019 | Current |
Pravin Trama ![]() | Director | 01-Oct-2019 | Current |
Rupendra Singh ![]() | Whole-Time Director | 25-May-2022 | Current |
Financial Performance of Bayer Bioscience.
Bayer Bioscience Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.12% decrease. The company also saw a substantial fall in profitability, with a 73.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 61.67%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Bayer Bioscience?
In 2023, Bayer Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Bayer Cropscience Limited
Simon Wiebusch is a mutual person
- Mahyco Monsanto Biotech (India) Private Limited
Simon Wiebusch and Pravin Trama are mutual person
Charges (Loans)
₹62.21 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of Travancore : 52.41 Cr
- State Bank Of Hyderabad : 5.00 Cr
- Indusind Bank Ltd. : 3.80 Cr
- Syndicate Bank : 1.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
03 Jun 1997 | Indusind Bank Ltd. | ₹3.80 Cr | Open |
03 Jan 1997 | State Bank Of Travancore | ₹21.75 Cr | Open |
29 Mar 1995 | Syndicate Bank | ₹1.00 Cr | Open |
17 Jun 1994 | State Bank Of Hyderabad | ₹5.00 Cr | Open |
09 May 1994 | State Bank Of Travancore | ₹14.01 Cr | Open |
How Many Employees Work at Bayer Bioscience?
Unlock and access historical data on people associated with Bayer Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Bayer Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bayer Bioscience's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Bayer Bioscience
Recent activity within the organization
- Annual General Meeting
Bayer Bioscience Private Limited last Annual general meeting of members was held on 22 Sep 2023 as per latest MCA records.
- Balance Sheet
Bayer Bioscience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
- Director Appointment
Rupendra Singh was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 25 May 2022 & has been associated with this company since 2 years 10 months .
- Director Appointment
Pravin Kumar Trama was appointed as a Director was appointed as a Director on 01 Oct 2019 & has been associated with this company since 5 years 6 months .
- Director Appointment
Simon Thorsten Wiebusch was appointed as a Director was appointed as a Director on 23 Jan 2019 & has been associated with this company since 6 years 2 months .
- Charges
A charge with Indusind Bank Ltd. amounted to Rs. 3.80 Cr with Charge ID 90046851 was registered on 03 Jun 1997.
Recent News, Updates & Announcement
- Biocon Biologics settles patent issue; paves way for launch of biosimilar product in Canada.
Biocon Biologics has settled patent disputes with Bayer Inc and Regeneron Pharmaceuticals Inc, enabling the launch of Yesafili, an ophthalmology product for neovascular and age-related macular degeneration, in Canada by July 1, 2025..
- Sun Pharma inks pact with Bayer to sell drug for chronic kidney disease.
Sun Pharma has partnered up with Bayer to market Finerenone, a drug for chronic kidney disease, in India. Bayer grants non-exclusive rights to Sun Pharma to distribute Finerenone under the brand name Lyvelsa. Sun Pharma CEO emphasizes commitment to providing innovative medicines to Indian patients. .
- Bayer’s move to block Natco’s colorectal cancer brand dismissed by Delhi HC.
Bayer raised the objection against Natcos brand launched under the name Regonat alleging infringement of its patent rights..
Frequently asked questions
What is the Incorporation or founding date of Bayer Bioscience Private Limited?
Bayer Bioscience Private Limited was incorporated on 28 Feb 1977.
What is authorized share capital and paid-up capital of Bayer Bioscience Private Limited?
The authorized share capital of Bayer Bioscience Private Limited is ₹ 10.00 Cr and paid-up capital is ₹ 8.36 Cr.
Who are the current board members & directors of Bayer Bioscience Private Limited?
Currently 3 directors are associated with Bayer Bioscience Private Limited.
- Simon Thorsten Wiebusch
- Pravin Kumar Trama
- Rupendra Singh
What is the registered address of Bayer Bioscience Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Bayer Bioscience Private Limited is Bayer House Central Avenue Hiranandani Estate, India, Thane West, Maharashtra, 400607.
What is the corporate identification number (CIN) and company number of Bayer Bioscience Private Limited?
The corporate identification number (CIN) of Bayer Bioscience Private Limited is U74899MH1977PTC179722 and the company number is 179722 as per Ministry of Corporate Affairs (MCA).
What is the official website of Bayer Bioscience Private Limited?
The Official website of Bayer Bioscience Private Limited is https://www.bayer.com
What has been the recent revenue trend for Bayer Bioscience Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Bayer Bioscience Private Limited has fallen by -24.12%.
What change has been observed in the net worth of Bayer Bioscience Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Bayer Bioscience Private Limited has experienced an downturn of -61.67%.
What are the total open charges for Bayer Bioscience Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Bayer Bioscience Private Limited amount to ₹ 62.21 Cr.
When was the last Balance Sheet of Bayer Bioscience Private Limited filed with the ROC?
The most recent Balance Sheet for Bayer Bioscience Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
- Alex MeregeCasual Vacancy Director
JH
Jens HartmannManaging DirectorCP
Clive PeggDirectorFM
Fidahusein MerchantDirectorFA
Frederic ArboucalotDirectorMK
Mahesh KumarDirectorSP
Satish PatilDirectorPK
Pradnesh KamatDirector and Key Managerial Personnel
Similar Companies Based on Seed Production & Distribution
- National Fertilizers Limited Delhi, India
- Gokul Agri International Limited Patan, Gujarat, India
- Sael Agri Commodities Limited Muktsar, Punjab, India
- Green Agrevolution Private Limited Patna, Bihar, India
- Dharampal Satyapal Limited Delhi, India
- Corteva Agriscience Seeds Private Limited Hyderabad, Telangana, India
- Jain Irrigation Systems Limited Jalgaon, Maharashtra, India
- Dcm Shriram Limited Delhi, India